A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer.

@article{Zarogoulidis2001API,
  title={A Phase II study of docetaxel and carboplatin in the treatment of non-small cell lung cancer.},
  author={Konstantinos Zarogoulidis and Th Kontakiotis and P Hatziapostolou and E Fachantidou and Dimitrios Delis and J Goutsikas and Theodoros C. Constantinidis and Athanasios Athanasiadis and Dimitrios Patakas},
  journal={Lung cancer},
  year={2001},
  volume={32 3},
  pages={281-7}
}
We investigated the efficacy of docetaxel (D) in combination with carboplatin (C) in the treatment of non-small cell lung cancer (NSCLC) patients. Since 1996, 123 with inoperable NSCLC were enrolled in the study; 120 (108 males, 12 females; mean age 58.0+/-8.3 years) were evaluated. Of those, 46 patients had squamous carcinoma, 44 adenocarcinoma, 11 large cell carcinoma and 19 undifferentiated tumours. Eligibility criteria included, documented inoperable NSCLC, WHO performance status (PS) 0-1… CONTINUE READING
11 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…